InspireMD (NSPR) Income from Continuing Operations (2010 - 2026)
InspireMD (NSPR) posted Income from Continuing Operations of -$14.4 million for Q2 2026, down 3.34% on a QoQ basis from -$14.0 million in Q1 2026, and down 10.95% year-over-year from -$16.2 million in Q2 2025.
Powered by 
Analysis
InspireMD (NSPR) Income from Continuing Operations (2010 - 2026) Analysis & Trends
InspireMD has reported Income from Continuing Operations for 17 years, with the latest figure at -$14.4 million in Q2 2026.
- On a quarterly basis, Income from Continuing Operations fell 10.95% year-over-year to -$14.4 million in Q2 2026; TTM through Jun 2026 was -$53.6 million, a 26.59% decrease from a year earlier, with the FY2025 full-year figure at -$38.5 million, down 52.52% from the prior year.
- Income from Continuing Operations was -$14.4 million for Q2 2026 at InspireMD, down from -$14.0 million in the prior quarter.
- The five-year high for Income from Continuing Operations was -$4.4 million in Q1 2023, with the low at -$14.4 million in Q2 2026.
- Average Income from Continuing Operations over 5 years is -$8.4 million, with a median of -$7.8 million recorded in 2024.
- The sharpest annual moves came in 2023 and 2024: Income from Continuing Operations climbed 2.23% in 2023, then sank 69.23% in 2024.
- Over 5 years, Income from Continuing Operations stood at -$4.8 million in 2022, then slipped by 20.57% to -$5.8 million in 2023, then plunged by 61.28% to -$9.4 million in 2024, then decreased by 29.01% to -$12.1 million in 2025, then decreased by 19.54% to -$14.4 million in 2026.
- The last three Income from Continuing Operations figures came in at -$14.4 million (Q2 2026), -$14.0 million (Q1 2026), and -$12.1 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.57 Bn | 178.97 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Intuitive Surgical | 124.13 Bn | 118.91 Bn | 1.96 Bn | 823.20 Mn |
| 3 | Medtronic | 118.29 Bn | 109.47 Bn | 6.34 Bn | 1.48 Bn |
| 4 | Stryker | 104.60 Bn | 101.12 Bn | 4.50 Bn | 1.28 Bn |
| 5 | Boston Scientific | 66.50 Bn | 65.97 Bn | 3.85 Bn | 905.00 Mn |
| 6 | Edwards Lifesciences | 49.72 Bn | 45.46 Bn | 1.35 Bn | 241.40 Mn |
| 7 | Alcon | 33.97 Bn | 32.51 Bn | 1.68 Bn | -92.00 Mn |
| 8 | Dexcom | 32.23 Bn | 30.29 Bn | 830.00 Mn | 249.10 Mn |
| 9 | Steris | 21.16 Bn | 20.68 Bn | 684.20 Mn | 201.00 Mn |
| 10 | InspireMD | 68.93 Mn | 38.51 Mn | -774,000.00 | -14.45 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -14.45 Mn |
| Mar 31, 2026 | -13.98 Mn |
| Dec 31, 2025 | -12.08 Mn |
| Sep 30, 2025 | -13.05 Mn |
| Jun 30, 2025 | -13.02 Mn |
| Mar 31, 2025 | -11.46 Mn |
| Dec 31, 2024 | -9.37 Mn |
| Sep 30, 2024 | -8.46 Mn |
| Jun 30, 2024 | -8.26 Mn |
| Mar 31, 2024 | -7.41 Mn |
| Dec 31, 2023 | -5.81 Mn |
| Sep 30, 2023 | -5.64 Mn |
| Jun 30, 2023 | -5.32 Mn |
| Mar 31, 2023 | -4.38 Mn |
| Dec 31, 2022 | -4.82 Mn |
| Sep 30, 2022 | -4.53 Mn |
| Jun 30, 2022 | -4.64 Mn |
| Mar 31, 2022 | -4.48 Mn |
| Dec 31, 2021 | -4.05 Mn |
| Sep 30, 2021 | -4.07 Mn |